1 BTC
=
- USD
Revance Therapeutics, Inc.
As of May 30, 2026 at 24:05 UTC
Chart
About Revance Therapeutics, Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
Market Statistics
Trading Metrics
How to Buy RVNC
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy RVNC
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesA class action lawsuit has been filed against Revance Therapeutics, Inc. (RVNC) for alleged violations of federal securities laws during the class period of February 29, 2024 to December 6, 2024. The lawsuit claims that the company made materially false and misleading statements regarding its business, operations, and prospects.
A class action lawsuit has been filed against Revance Therapeutics, Inc. (RVNC) for alleged violations of federal securities laws during the class period of February 29, 2024 to December 6, 2024. The lawsuit alleges that the company made materially false and misleading statements regarding its business, operations, and prospects.
Bragar Eagel & Squire, P.C. has filed class action lawsuits against BioAge Labs, Inc. and Revance Therapeutics, Inc. on behalf of their stockholders. The lawsuits allege that the companies made materially false and/or misleading statements regarding their business, operations, and prospects.